Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, 5S ribosomal pseudogene 51 (RNA5SP51) is a human pseudogene derived from the 5S ribosomal RNA gene family. The functional 5S ribosomal RNA (5S rRNA) is a ~120 nucleotide non-coding RNA component of the large ribosomal subunit, playing a structural and functional role in protein synthesis and ribosome assembly[1][5]. Pseudogenes like RNA5SP51 are non-functional copies or fragments of 5S rRNA genes found throughout the genome, and typically lack the ability to produce functional RNA transcripts or proteins. Although pseudogenes are generally considered "genomic fossils", some ribosomal RNA pseudogenes are known to be transcribed, and may participate in gene regulation at the RNA level or through the production of small interfering RNAs, but these functions are mostly speculative and have not been specifically demonstrated for RNA5SP51[2][6]. RNA5SP51 is primarily used as a genomic marker, and there is no known role in disease, drug interaction, or therapeutic targeting. The rich family of 5S rRNA pseudogenes reflects the repetitive and evolutionary nature of ribosomal gene clusters in eukaryotic genomes[1][5]. Some research on other 5S rRNA pseudogenes (e.g., RNA5SP141) has highlighted roles in innate immune sensing, suggesting that in some contexts, pseudogenes may be more active molecular participants; however, this appears to be specific to certain pseudogene transcripts and not a general feature[4]. There is no evidence that RNA5SP51 encodes a receptor, enzyme, transporter, or other canonical "therapeutic target" class. This entry highlights the non-coding, non-target status of this pseudogene, and that it should not be conflated with the functional 5S rRNA or its protein-coding analogs.
None known (no documented drug targeting or mechanism of action for this pseudogene)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 5S ribosomal pseudogene 51 (RNA5SP51).